UNSPSC 51102849: Flurandrenolide/neomycin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE250. This VA Drug Class (DE250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL.

UNSPSC 51102849 Flurandrenolide/neomycin is a Commodity code used infrequently in recent state and local procurement activity. The code nominally designates a specific topical anti-inflammatory and antimicrobial pharmaceutical combination, yet the recent opportunities tagged to it span unrelated pharmaceutical products—antibiotic tablets and opioid-reversal agents—indicating misalignment between the code's intended scope and actual tagging practice in state and local systems. State and local buyers do solicit pharmaceuticals through piggyback contracts and competitive bidding, but the mismatch between the code's stated product and the work actually being bought suggests this code is either underused or inconsistently applied across issuing bodies.

Activity appears concentrated in Florida and Illinois, based on two recent records posted between June and August 2026. The Illinois Department of Public Health executed a piggyback pharmaceutical warehouse order through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for antibiotics—Doxycycline Hyclate and Ciprofloxacin Hydrochloride—totaling $2,999,999.11 over the contract term under an Invitation for Bid process. Separately, Seminole County, Florida posted an IFB on June 30, 2026 (response due July 26, 2023 per the record), seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building. Both opportunities reflect state and county health procurement, but neither involves flurandrenolide/neomycin or a topical formulation. The code shows minimal traction and material decision value turns on clarifying whether recent tagging reflects system error or actual procurement intent for this specific therapeutic.